The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.
The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.
© 2021 LVL Network. Site Notice. Privacy Policy.